Breaking News


Karnauskas Favors Amgen Purchase of Onyx (Audio)

Robyn Karnauskas, a New York-based analyst at Deutsche Bank AG, says Amgen's purchase of Onyx Pharmaceuticals Inc. (ONXX) gives Amgen "top line growth" in the cancer-drug market. Karnauskas talks with Bloomberg's Tom Keene and Joe Brusuelas on Bloomberg Radio's "Bloomberg Surveillance."

(Source: Bloomberg)

Running time 05:38

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.